| Name | Title | Contact Details |
|---|
Orion Health is a global, award-winning provider of health information technology, advancing population health and precision medicine solutions for the delivery of care across the entire health ecosystem. Founded in 1993, Orion Health`s focus for 28 years has been on delivering software, services and support for healthcare organisations that empower clinicians and caregivers with the right information to deliver the best possible care. We specialise in open technology systems that seamlessly integrate all forms of health and personal data across the entire health community and present that data back to users in real-time to provide optimum patient care. We believe that software needs to do more than serve up data; it needs to provide insights in real-time to the people who need it when they need it. We provide a smart suite of solutions that enable clinicians to extract meaningful insights and make more accurate decisions about patient care. Delivering patient-centred healthcare and quality health outcomes that help patients live a healthier life. Orion Health employs 500+ people in 20 offices across 13 countries. Our technology is used by hundreds of thousands of clinicians worldwide to manage the health care of more than 100 million patients. With the most widely deployed population health management platform globally; more than 55 large-scale (regional and country-wide) solutions successfully deployed in over 15 countries, we provide the world`s number one health information platform.
Maryland Health Benefit Exchange’s (MHBE) resource site for stakeholders. We continue to work toward the opening of the marketplace in October 2013 of Maryland Health Connection, the state-based health insurance exchange where Maryland residents and small businesses will be able to explore and compare health insurance plans, qualify for cost-sharing reductions and tax credits and complete the enrollment process. The information available through this site supports our work with stakeholders. Meeting schedules and materials, career information, and procurement details are routinely posted. Additionally, the site serves as a resource for the many advisory committees and programs in progress and in development as we collectively work together to establish a health insurance marketplace that best meets the needs of all Marylanders.
A global decentralized health platform that empowers patients with a self-sovereign health identity and aligns patients, providers, and payers to battle the global pandemic of chronic disease
Imperial Health is a network of physicians collaborating together to offer advanced medical care services to the residents of Southwest Louisiana.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.